Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study

Genomic instability of circulating tumor DNA (ctDNA) as a prognostic biomarker has not been evaluated in pancreatic cancer. We investigated the role of the genomic instability index of ctDNA in pancreatic ductal adenocarcinoma (PDAC). We prospectively enrolled 315 patients newly diagnosed with resec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sang Myung Woo, Min Kyeong Kim, Boram Park, Eun-Hae Cho, Tae-Rim Lee, Chang-Seok Ki, Kyong-Ah Yoon, Yun-Hee Kim, Wonyoung Choi, Do Yei Kim, Jin-Hyeok Hwang, Jae Hee Cho, Sung-Sik Han, Woo Jin Lee, Sang-Jae Park, Sun-Young Kong
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/bf9fbe86bba14691a2b17839372df15f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bf9fbe86bba14691a2b17839372df15f
record_format dspace
spelling oai:doaj.org-article:bf9fbe86bba14691a2b17839372df15f2021-11-11T15:33:34ZGenomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study10.3390/cancers132154662072-6694https://doaj.org/article/bf9fbe86bba14691a2b17839372df15f2021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5466https://doaj.org/toc/2072-6694Genomic instability of circulating tumor DNA (ctDNA) as a prognostic biomarker has not been evaluated in pancreatic cancer. We investigated the role of the genomic instability index of ctDNA in pancreatic ductal adenocarcinoma (PDAC). We prospectively enrolled 315 patients newly diagnosed with resectable (<i>n</i> = 110), locally advanced (<i>n</i> = 78), and metastatic (<i>n</i> = 127) PDAC from March 2015 through January 2020. Low-depth whole-genome cell-free DNA sequencing identified genome-wide copy number alterations using instability score (I-score) to reflect genome-wide instability. Plasma cell-free and matched tumor tissue DNA from 15 patients with resectable pancreatic cancer was sequenced to assess the concordance of chromosomal copy number alteration profiles. Associations of I-score with clinical factors or survival were assessed. Seventy-six patients had high genomic instability with I-score > 7.3 in pre-treatment ctDNA; proportions of high I-score were 5.5%, 5.1%, and 52% in resectable, locally advanced, and metastatic stages, respectively. Correlation coefficients between Z-scores of plasma and tissue DNA at segment resolution were high (r<sup>2</sup> = 0.82). Univariable analysis showed the association of I-score with progression-free survival in each stage. Multivariable analyses demonstrated that clinical stage-adjusted I-scores were significant factors for progression-free and overall survival. In these patients, ctDNA genomic I-scores provided prognostic information relevant to progression-free survival in each clinical stage.Sang Myung WooMin Kyeong KimBoram ParkEun-Hae ChoTae-Rim LeeChang-Seok KiKyong-Ah YoonYun-Hee KimWonyoung ChoiDo Yei KimJin-Hyeok HwangJae Hee ChoSung-Sik HanWoo Jin LeeSang-Jae ParkSun-Young KongMDPI AGarticlepancreatic ductal adenocarcinomagenomic instabilityprognostic biomarkeroutcome predictioninstability scorecirculating tumor DNANeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5466, p 5466 (2021)
institution DOAJ
collection DOAJ
language EN
topic pancreatic ductal adenocarcinoma
genomic instability
prognostic biomarker
outcome prediction
instability score
circulating tumor DNA
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle pancreatic ductal adenocarcinoma
genomic instability
prognostic biomarker
outcome prediction
instability score
circulating tumor DNA
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Sang Myung Woo
Min Kyeong Kim
Boram Park
Eun-Hae Cho
Tae-Rim Lee
Chang-Seok Ki
Kyong-Ah Yoon
Yun-Hee Kim
Wonyoung Choi
Do Yei Kim
Jin-Hyeok Hwang
Jae Hee Cho
Sung-Sik Han
Woo Jin Lee
Sang-Jae Park
Sun-Young Kong
Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study
description Genomic instability of circulating tumor DNA (ctDNA) as a prognostic biomarker has not been evaluated in pancreatic cancer. We investigated the role of the genomic instability index of ctDNA in pancreatic ductal adenocarcinoma (PDAC). We prospectively enrolled 315 patients newly diagnosed with resectable (<i>n</i> = 110), locally advanced (<i>n</i> = 78), and metastatic (<i>n</i> = 127) PDAC from March 2015 through January 2020. Low-depth whole-genome cell-free DNA sequencing identified genome-wide copy number alterations using instability score (I-score) to reflect genome-wide instability. Plasma cell-free and matched tumor tissue DNA from 15 patients with resectable pancreatic cancer was sequenced to assess the concordance of chromosomal copy number alteration profiles. Associations of I-score with clinical factors or survival were assessed. Seventy-six patients had high genomic instability with I-score > 7.3 in pre-treatment ctDNA; proportions of high I-score were 5.5%, 5.1%, and 52% in resectable, locally advanced, and metastatic stages, respectively. Correlation coefficients between Z-scores of plasma and tissue DNA at segment resolution were high (r<sup>2</sup> = 0.82). Univariable analysis showed the association of I-score with progression-free survival in each stage. Multivariable analyses demonstrated that clinical stage-adjusted I-scores were significant factors for progression-free and overall survival. In these patients, ctDNA genomic I-scores provided prognostic information relevant to progression-free survival in each clinical stage.
format article
author Sang Myung Woo
Min Kyeong Kim
Boram Park
Eun-Hae Cho
Tae-Rim Lee
Chang-Seok Ki
Kyong-Ah Yoon
Yun-Hee Kim
Wonyoung Choi
Do Yei Kim
Jin-Hyeok Hwang
Jae Hee Cho
Sung-Sik Han
Woo Jin Lee
Sang-Jae Park
Sun-Young Kong
author_facet Sang Myung Woo
Min Kyeong Kim
Boram Park
Eun-Hae Cho
Tae-Rim Lee
Chang-Seok Ki
Kyong-Ah Yoon
Yun-Hee Kim
Wonyoung Choi
Do Yei Kim
Jin-Hyeok Hwang
Jae Hee Cho
Sung-Sik Han
Woo Jin Lee
Sang-Jae Park
Sun-Young Kong
author_sort Sang Myung Woo
title Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study
title_short Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study
title_full Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study
title_fullStr Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study
title_full_unstemmed Genomic Instability of Circulating Tumor DNA as a Prognostic Marker for Pancreatic Cancer Survival: A Prospective Cohort Study
title_sort genomic instability of circulating tumor dna as a prognostic marker for pancreatic cancer survival: a prospective cohort study
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/bf9fbe86bba14691a2b17839372df15f
work_keys_str_mv AT sangmyungwoo genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT minkyeongkim genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT borampark genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT eunhaecho genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT taerimlee genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT changseokki genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT kyongahyoon genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT yunheekim genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT wonyoungchoi genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT doyeikim genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT jinhyeokhwang genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT jaeheecho genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT sungsikhan genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT woojinlee genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT sangjaepark genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
AT sunyoungkong genomicinstabilityofcirculatingtumordnaasaprognosticmarkerforpancreaticcancersurvivalaprospectivecohortstudy
_version_ 1718435208603107328